Tavotek Biotherapeutics

Headquarters

Unknown, US

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company leverages proprietary antibody engineering platforms to generate high-affinity, high-specificity antibodies targeting disease-relevant antigens in Oncology and Immunology.

• Levolta Pharmaceuticals, IncLevolta Pharmaceuticals is an innovative, clinical-stage pharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of rheumatology, immunology, and cancer. The company is driven to overcome current treatment barriers by developing products with an enhanced therapeutic index that drive customer value. Its lead product, VOLT01, is a novel proprietary derivative of zoledronic acid (ZA) that has demonstrated enhanced efficacy and safety in treating osteoarthritis.BETHLEHEM, PA
• AdaptimmuneAdaptimmune focuses on designing and delivering novel cancer immunotherapy products, specifically T-cell receptor (TCR) T-cell therapies. The company utilizes a proprietary TCR platform to identify cancer targets and genetically engineer TCRs to recognize and attack these targets, producing autologous T-cell treatments. Adaptimmune has a preclinical pipeline with multiple cell therapy approaches and manufactures products at its Navy Yard facility in Philadelphia, PA.541714PHILADELPHIA, PA
• TerSera Therapeutics LLCTerSera is a biopharmaceutical company focused on developing and commercializing therapeutics, particularly in oncology and non-opioid pain. The company provides patient support services and partners with other organizations to deliver life-changing treatments.DEERFIELD, IL
• Generian PharmaceuticalsGenerian Pharmaceuticals is a preclinical biotechnology company focused on discovering and developing orally available small molecule therapeutics for diseases with high unmet need, specifically areas dominated by biologics. The company leverages a proprietary drug discovery platform to screen proteins in their native cellular environment and advance first-in-class drug candidates that modulate target protein structure and/or dynamics.